GYUNGGI-DO, South Korea, Feb. 16, 2026 /PRNewswire/ — Endoplasmic reticulum (ER) stress and the unfolded protein response are often implicated in the progressionGYUNGGI-DO, South Korea, Feb. 16, 2026 /PRNewswire/ — Endoplasmic reticulum (ER) stress and the unfolded protein response are often implicated in the progression

Hanyang University ERICA Researchers Identify Key Mechanism Driving Progression of Fatty Liver Disease to Cancer

2026/02/16 22:15
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

GYUNGGI-DO, South Korea, Feb. 16, 2026 /PRNewswire/ — Endoplasmic reticulum (ER) stress and the unfolded protein response are often implicated in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD), from simple steatosis to inflammation-driven metabolic dysfunction-associated steatohepatitis and, ultimately, hepatocellular carcinoma. A new review paper from Hanyang University ERICA sheds light on the mechanisms underlying these processes, advocating for precise hepatic ER stress control to maintain normal hepatocyte function and develop therapeutic strategies against MASLD.

According to recent reports from the Korean government, the incidence of alcoholic liver disease—previously the leading indication for liver transplantation—has been decreasing. This trend initially raised expectations that the medical burden of liver transplantation and liver-related mortality would decline. However, the current reality does not reflect this expectation. In addition, fatty liver disease is also increasing steadily due to modern lifestyle factors, and projections indicate that the demand for liver transplantation will continue to rise, with fatty liver-related cases increasingly replacing those caused by alcoholic liver disease.

Alarmingly, nonalcoholic fatty liver disease, now re-termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects nearly 30% of the global population. It is strongly linked to endoplasmic reticulum (ER) stress. The ER is a dynamic membranous organelle that constitutes about half of the membrane content in liver cells and acts as the main hub for protein folding and lipid biosynthesis. Notably, the unfolded protein response (UPR) is a key mechanistic stress regulator that influences disease progression from simple steatosis to inflammation-driven metabolic dysfunction-associated steatohepatitis (MASH) and eventually hepatocellular carcinoma—the third leading cause of cancer-related mortality worldwide.

An international team of researchers—led by Associate Professor Ju Youn Kim from the Major in Molecular Medicine, School of Bio-Pharmaceutical Convergence, Hanyang University ERICA, Republic of Korea—has comprehensively investigated how ER stress and the UPR drive the progression of MASLD from simple fatty liver to MASH and liver cancer. Their novel insights were made available online on October 14, 2025, and were published in Volume 77, Issue 6 of the journal Pharmacological Reviews on November 1, 2025.

Dr. Kim elaborates on the motivation behind their work: “Hepatocytes—the main functional cells of the liver—are the largest cell population responsible for systemic protein distribution through ER-regulated protein synthesis. This makes the precise control of hepatic ER stress essential not only for maintaining normal hepatocyte function but also for developing therapeutic strategies against ER stress-driven MASLD. Therefore, we have systematically summarized the current knowledge in this field.”

The comprehensive analysis examines therapeutic strategies targeting ER stress pathways, including recently approved GLP-1 receptor agonists, and explores the brain-liver connection in metabolic disease progression. The article further highlights newly identified molecular mechanisms underlying the progression of advanced MASH to MASH-related cirrhosis and hepatocellular carcinoma. In particular, the team focuses on the role of hepatic ER stress in hepatocyte injury and stress responses within a lipid-overloaded liver tissue context.

“Our review paper provides pathogenic insights into how lifestyle-associated fatty liver disease—driven by overeating, physical inactivity, and alcohol consumption—can ultimately progress to life-threatening conditions such as cirrhosis and hepatocellular carcinoma,” highlights Dr. Kim. “By offering science-based medical insights, we aim to contribute to the reduction of fatty liver disease incidence and its associated mortality.”

Overall, this work presents a holistic framework for understanding ER-mediated metabolic outcomes and can guide future research on the development of novel therapeutic strategies.

Reference
Title of original paper: Endoplasmic reticulum stress at the forefront of fatty liver diseases and cancer
Journal: Pharmacological Reviews
DOI: 10.1016/j.pharmr.2025.100096

About Hanyang University ERICA
Website: https://www.hanyang.ac.kr/web/eng/erica-campus1

Media Contact:
Jin-Mo An
409099@email4pr.com
82-31-400-4947

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/hanyang-university-erica-researchers-identify-key-mechanism-driving-progression-of-fatty-liver-disease-to-cancer-302687784.html

SOURCE Hanyang University

Market Opportunity
Bitlight Labs Logo
Bitlight Labs Price(LIGHT)
$0.1853
$0.1853$0.1853
-1.90%
USD
Bitlight Labs (LIGHT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

OpenClaw API Integration Is Live in the Crypto.com App: Here’s What Traders Need to Know

OpenClaw API Integration Is Live in the Crypto.com App: Here’s What Traders Need to Know

TLDR: OpenClaw API integration is now live in the Crypto.com App via the new Agent Key feature for traders. Users can set weekly trading budgets to cap how much
Share
Blockonomi2026/03/03 19:30
The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum

The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum

The post The Best Crypto Presale in 2025? Solana and ADA Struggle, but Lyno AI Surges With Growing Momentum appeared on BitcoinEthereumNews.com. With the development of 2025, certain large cryptocurrencies encounter continuous issues and a new player secures an impressive advantage. Solana is struggling with congestion, and the ADA of Cardano is still at a significantly lower level than its highest price. In the meantime, Lyno AI presale is gaining momentum, attracting a large number of investors. Solana Faces Setbacks Amid Market Pressure However, despite the hype surrounding ETFs, Solana fell by 7% to $ 203, due to the constant congestion problems that hamper its network functionality. This makes adoption slow and aggravates traders who want to get things done quickly. Recent upgrades should combat those issues but the competition is rising, and Solana continues to lag in terms of user adoption and ecosystem development. Cardano Struggles to Regain Momentum ADA, the token of a Cardano, costs 72% less than the 2021 high and is developing more slowly than Ethereum Layer 2 solutions. The adoption of the coin is not making any progress despite the good forecasts. Analysts believe that the road to regain the past heights is long before Cardano can go back, with more technological advancements getting more and more attention. Lyno AI’s Explosive Presale Growth In stark contrast, Lyno AI is currently in its Early Bird presale, in which tokens are sold at 0.05 per unit and have already sold 632,398 tokens and raised 31,462 dollars. The next stage price will be established at $0.055 and the final target will be at $0.10. Audited by Cyberscope , Lyno AI provides a cross-chain AI arbitrage platform that enables retail traders to compete with institutions. Its AI algorithms perform trades in 15+ blockchains in real time, opening profitable arbitrage opportunities to everyone. Those who make purchases above 100 dollars are also offered the possibility of winning in the 100K Lyno AI…
Share
BitcoinEthereumNews2025/09/18 18:22
What to Expect From The Fed This Year After First Rate Cut in 2025

What to Expect From The Fed This Year After First Rate Cut in 2025

The United States central bank has just cut rates for the first time this year, and investors are now watching for its next move.
Share
CryptoPotato2025/09/18 13:02